Clinical impact of subcutaneous treprostinil in trisomy 21 patient with pulmonary arterial hypertension associated with CHD

Subcutaneous treprostinil is commonly used to improve idiopathic pulmonary arterial hypertension in children. However, its effectiveness has not been reported in trisomy 21. We report the case of 9-year-old boy in trisomy 21 with CHD-pulmonary artery hypertension after surgical correction of CHD. Ha...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cardiology in the young 2022-09, Vol.32 (9), p.1502-1504
Hauptverfasser:	Numata, Ryusuke, Takigiku, Kiyohiro, Takei, Kouta
Format:	Artikel
Sprache:	eng
Schlagworte:	Airway management Cardiac catheterization Catheters Down syndrome General Cardiology Hemodynamics Hypertension Intellectual disabilities Patients Pediatrics Pulmonary arteries Pulmonary artery Pulmonary hypertension Surgery Trisomy Veins & arteries
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!